Oct 7
|
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
|
Oct 2
|
Abivax Highlights Obefazimod Ulcerative Colitis Program With New Data to be Presented at the UEG Week 2023
|
Sep 29
|
Abivax Files Registration Statement for Proposed Initial Public Offering in the United States
|
Aug 23
|
Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations
|
Aug 21
|
Abivax Secures Up to EUR 150M from Two Structured Debt Financing Transactions
|